---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-001616"
form_type: "8-K/A"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2024-01-05T23:59:59+00:00"
generated_at: "2026-06-07T03:03:10.570319+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx completes acquisition of Medicx Health; FY2022 revenue $28.1M

## Summary
- Medicx FY2022: revenue $28.1M, net income $4.5M; FY2021: revenue $18.5M, net income $0.8M.
- Deal closed Oct 24, 2023; this amendment provides audited and pro forma financials.
- Medicx balance sheet Dec 2022: total assets $18.6M, stockholders' equity $12.4M.
- Pro forma combined balance sheet at June 30, 2023 and statements of ops included.
- Medicx revenue grew 51% YoY from 2021 to 2022; net income increased 5.8x.

## SEC filing metadata
- accession: 0001213900-24-001616
- form_type: 8-K/A
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2024-01-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390024001616/0001213900-24-001616-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390024001616/ea191205-8ka1_optimizerx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-001616
- JSON: https://secwatch.observer/filing/0001213900-24-001616.json
- Plain text: https://secwatch.observer/filing/0001213900-24-001616.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.